Retrospective Cohort Study
Copyright ©The Author(s) 2018.
World J Hepatol. Oct 27, 2018; 10(10): 731-742
Published online Oct 27, 2018. doi: 10.4254/wjh.v10.i10.731
Table 1 Baseline characteristics of included patients
VariableOverall (n = 134)CSPH (LSM ≥ 21 kPa) (n = 60)No CSPH (LSM < 21 kPa) (n = 74)
Age (yr)60 (51-69)57 (50.5-65)61.5 (51-70)
Male92 (68.7)42 (70)50 (67.6)
HCV-genotype
195 (70.9)41 (68.3)54 (72.5)
212 (8.9)4 (6.7)8 (10.8)
320 (14.9)11 (18.3)9 (12.2)
47 (5.3)4 (6.7)3 (4.5)
Treatment regimen
SOF/RBV33 (24.6)10 (16.7)23 (31.1)
SOF/SMV29 (21.6)15 (25)14 (18.9)
SOF/DCV38 (28.4)19 (31.6)19 (25.6)
SOF/LDV16 (12)7 (11.7)9 (12.2)
Other18 (13.4)9 (15)9 (12.2)
Child Pugh Score
A115 (85.8)52 (86.7)63 (85.1)
B19 (14.2)8 (13.3)11 (14.9)
MELD Score8 (7-10)9 (8-10)8 (7-10)
Spleen Diameter (cm)14 (12.3-15.5)14.7 (12.8-15.8)13.9 (12.1-15)
Laboratory results
Platelets (cells × 109/L)110 (79-150)102 (74-132)134 (92-159)
ALT (U/L)58 (39-95)55 (39-84)60 (38-105)
Bilirubin (mg/dL)0.9 (0.67-1.29)1 (0.84-1.52)0.8 (0.6-1.1)
Albumin (g/dL)3.8 (3.6-4.1)3.8 (3.5-4.1)3.8 (3.6-4.1)
Creatinine (mg/dL)0.8 (0.7-0.98)0.8 (0.70-0.96)0.85 (0.71-1.08)
INR1.1 (1.06-1.2)1.17 (1.1-1.21)1.08 (1.04-1.13)
NITs
SSM (kPa)58.8 (42.2-75)69.9 (55.7-75)46.2 (31.6-63.9)
LSM (kPa)19.3 (14.1-27)29.1 (23.9-39.7)14.6 (12-17)
LSPS2.78 (1.4-4.94)5.1 (3.05-7.48)1.58 (1.09-2.79)
Table 2 Liver and Spleen stiffness measurement decreases after sustained viral response
VariableOverall (n = 134)CSPH (LSM ≥ 21 kPa) (n = 60)No CSPH (LSM < 21 kPa) (n = 74)
Relative SSM decrease (%)12.3 (0-36.3)4.7 (0-32.5)20.4 (0-39.7)
Overall SSM decrease92 (68.7)40 (66.7)52 (70.3)
> 10%73 (54.5)31 (51.7)42 (56.8)
> 20%60 (44.8)23 (38.3)37 (50)
Relative LSM decrease (%)30 (13.5-42.4)28.3 (11.4-41.9)30.8 (13.9-42.4)
Overall LSM decrease114 (85.1)51 (85)63 (85.1)
> 10%108 (80.6)48 (80)60 (81.1)
> 20%88 (65.7)40 (66.7)48 (64.9)
PLT Increase (%)12.4 (-10.1 to 29.6)5.5 (-15.6 to 25.9)17.4 (-0.67 to 35.6)
Table 3 Univariate and multivariate analysis of factors associated with a SSM decrease > 20%
Entire Population (n = 134)
VariableUnivariate analysis
Multivariate analysis
LR Chi-2 = 16.48AIC = 171.8
AUROC = 0.6821BIC = 177.6
SSM Decrease >20% (n = 60)No SSM Decrease >20% (n = 74)OR (95%CI)P valueOR (95%CI)P value
Age (yr)62 (52-69)56 (50-68)1.005 (0.975-1.037)0.727
Sex (male)21 (28.4)21 (35)1.359 (0.653-2.828)0.412
Presence of varices (n = 67) (yes)9 (34.2)24 (82.8)0.110 (0.031-0.388)0.001
Spleen diameter (cm)13.6 (11.65-15.15)14.5 (13-16)0.800 (0.660-0.970)0.023
Child Pugh Score5 (5-6)5 (5-6)0.885 (0.601-1.303)0.535
Child Pugh Score B (yes)8 (13.3)11 (14.9)0.881 (0.330-2.352)0.801
MELD score8 (7-10)9 (8-10)0.786 (0.648-0.954)0.015
MELD > 1012 (20)30 (40.5)0.367 (0.167-0.804)0.012
AST (U/L)54.5 (38-85)56 (35.5-87)0.996 (0.987-1.004)0.322
ALT (U/L)62 (37-105)53 (40-90)1.002 (0.995-1.008)0.620
ALT ≥ 2 × ULN at BL59.5 (37.5-101)54 (40-91.5)1.326 (0.597-2.944)0.489
INR1.09 (1.05-1.17)1.12 (1.09-1.21)0.127 (0.001-0.551)0.023
Bilirubin (mg/dl)0.85 (0.65-1.16)1.02 (0.71-1.52)0.903 (0.535-1.525)0.703
Albumin (g/dl)3.8 (3.52-4.12)3.78 (3.52-4.12)2.096 (0.959-4.581)0.063
Creatinine (mg/d)0.8 (0.7-1)0.81 (0.69-0.93)0.327 (0.674-1.585)0.165
Platelet count (10^9/L)118 (92-154)91 (74-137)1.002 (0.996-1.007)0.579
LSM BL (kPa)18 (14.6-25.7)21.1 (14-38.5)0.988 (0.962-1.015)0.391
LSM SVR24 (kPa)12.4 (9.4-18)17.5 (10.4-32.4)0.944 (0.908-0.981)0.004
SSM BL (kPa)60.4 (45.7-70.7)53.2 (37.4-75)1.012 (0.992-1.032)0.225
LSPS BL2.17 (1.33-3.77)4.15 (1.65-6.26)0.817 (0.684-0.975)0.025
LSM decrease (Delta, %)33 (18.1–44.6)19.4 (0–31.3)0.0332 (0.005-0.225)< 0.00010.0332 (0.005-0.225)< 0.0001
LSM decrease > 10% (yes)54 (90)54 (73)3.333 (1.242-8.946)0.017
LSM decrease > 20% (yes)47 (78.3)41 (55.4)2.910 (1.352-6.262)0.006